{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:18:33Z","timestamp":1762870713751,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mayocpiqo.2020.05.007","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T11:48:13Z","timestamp":1597837693000},"page":"529-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-0614","authenticated-orcid":false,"given":"David","family":"Snipelisky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Nayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha M.","family":"Lever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Raymer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-0233","authenticated-orcid":false,"given":"Andrew N.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"AbouEzzeddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian F.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne Warner","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren G.","family":"Gilstrap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mayocpiqo.2020.05.007_bib1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cardfail.2017.06.009","article-title":"Unanswered questions in contemporary heart failure","volume":"23","author":"Gilstrap","year":"2017","journal-title":"J\u00a0Card Fail"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2020.05.007_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.hfc.2018.06.010","article-title":"Current status of inotropes in heart failure","volume":"14","author":"Ginwalla","year":"2018","journal-title":"Heart Fail Clin"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.05.007_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hrtlng.2007.05.001","article-title":"Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?","volume":"37","author":"Fares","year":"2008","journal-title":"Heart Lung"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2020.05.007_bib4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ahj.2015.09.001","article-title":"Differences in health care use and outcomes by the timing of in-hospital worsening heart failure","volume":"170","author":"Cooper","year":"2015","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2020.05.007_bib5","first-page":"368","article-title":"Effects of widespread inotrope use in acute heart failure patients","volume":"7","author":"Kang","year":"2018","journal-title":"J\u00a0Clin Med"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2020.05.007_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cardfail.2014.05.006","article-title":"Inotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiology","volume":"20","author":"Kalogeropoulos","year":"2014","journal-title":"J\u00a0Card Fail"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2020.05.007_bib7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCHEARTFAILURE.114.001778","article-title":"Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure","volume":"8","author":"Hashim","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.05.007_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ejhf.991","article-title":"Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry","volume":"20","author":"Mebazaa","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.mayocpiqo.2020.05.007_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IJGM.S62549","article-title":"Inotropes do not increase mortality in advanced heart failure","volume":"7","author":"Guglin","year":"2014","journal-title":"Int J Gen Med"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.05.007_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1573403X09666131117163825","article-title":"Advanced therapies for end-stage heart failure","volume":"11","author":"Katz","year":"2015","journal-title":"Curr Cardiol Rev"},{"year":"1999","series-title":"Outcomes Based Therapeutic Interchange: An ACE Inhibitor Interchange Program","author":"Dana","key":"10.1016\/j.mayocpiqo.2020.05.007_bib11"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.05.007_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCHEARTFAILURE.113.000761","article-title":"Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With the Guidelines","volume":"7","author":"Allen","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.05.007_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ahj.2006.09.005","article-title":"Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure","volume":"153","author":"Elkayam","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.mayocpiqo.2020.05.007_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.resuscitation.2015.04.006","article-title":"Mayo Registry for Telemetry Efficacy in Arrest (MR TEA) study: an analysis of code status following cardiopulmonary arrest","volume":"92","author":"Snipelisky","year":"2015","journal-title":"Resuscitation"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454820300990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454820300990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:09:03Z","timestamp":1762870143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454820300990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2542454820300990"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.05.007","relation":{},"ISSN":["2542-4548"],"issn-type":[{"type":"print","value":"2542-4548"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expected vs Actual Outcomes of Elective Initiation of Inotropic Therapy During Heart Failure Hospitalization","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}